Abiraterone in the treatment of metastatic castration-resistant prostate cancer

por Mostaghel, Elahe A
Publicado 2014

Beyond T and DHT - Novel Steroid Derivatives Capable of Wild Type Androgen Receptor Activation

por Mostaghel, Elahe A
Publicado 2014

Steroid hormone synthetic pathways in prostate cancer

por Mostaghel, Elahe A.
Publicado 2013

Statins and adrenal androgen levels in prostate cancer: A new twist

por Mostaghel, Elahe A
Publicado 2021

Preventive Therapy of Experimental Colitis with Selected iron Chelators and Anti-oxidants

por Minaiyan, Mohsen, Mostaghel, Elahe, Mahzouni, Parvin
Publicado 2012

Harnessing Solute Carrier Transporters for Precision Oncology

por Nyquist, Michael D., Prasad, Bhagwat, Mostaghel, Elahe A.
Publicado 2017

Glucocorticoids and prostate cancer treatment: friend or foe?

por Montgomery, Bruce, Cheng, Heather H, Drechsler, James, Mostaghel, Elahe A
Publicado 2014

Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors

por Mostaghel, Elahe A., Solomon, Keith R., Pelton, Kristine, Freeman, Michael R., Montgomery, R. Bruce
Publicado 2012

Role of OATP Transporters in Steroid Uptake by Prostate Cancer Cells in Vivo

por Green, Sean, Kaipainen, Arja, Bullock, Kristin, Zhang, Ailin, Lucas, Jared, Matson, Clint, Banks, William A, Mostaghel, Elahe A
Publicado 2016

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions

por Mohammad, Osama S., Nyquist, Michael D., Schweizer, Michael T., Balk, Stephen P., Corey, Eva, Plymate, Stephen, Nelson, Peter S., Mostaghel, Elahe A.
Publicado 2017

SAT-114 Loss of DHEA-Targeting SULT2b1b Sulfotransferase Exacerbates Aggressive Traits of Prostate Cancer

por Song, Chung Seog, Park, Sulgi, Jiang, Shoulei, Osmulski, Pawel, Marck, Brett T, Matsumoto, Alvin M, Morrissey, Colm, Gaczynska, Maria E, Mostaghel, Elahe A, Chatterjee, Bandana
Publicado 2020

A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors

por Qu, Xiaoyu, Randhawa, Grace, Friedman, Cynthia, Kurland, Brenda F., Glaskova, Lena, Coleman, Ilsa, Mostaghel, Elahe, Higano, Celestia S., Porter, Christopher, Vessella, Robert, Nelson, Peter S., Fang, Min
Publicado 2013

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

por Nyquist, Michael D., Coleman, Ilsa M., Lucas, Jared M., Li, Dapei, Hanratty, Brian, Meade, Hannah, Mostaghel, Elahe A., Plymate, Stephen R., Corey, Eva, Haffner, Michael C., Nelson, Peter S.
Publicado 2023

Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate

por Schweizer, Michael T., Cheng, Heather H., Tretiakova, Maria S., Vakar-Lopez, Funda, Klemfuss, Nola, Konnick, Eric Q., Mostaghel, Elahe A., Nelson, Peter S., Yu, Evan Y., Montgomery, Bruce, True, Lawrence D., Pritchard, Colin C.
Publicado 2016

Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer

por Allott, Emma H., Masko, Elizabeth M., Freedland, Alexis R., Macias, Everardo, Pelton, Kristine, Solomon, Keith R., Mostaghel, Elahe A., Thomas, George V., Pizzo, Salvatore V., Freeman, Michael R., Freedland, Stephen J.
Publicado 2018

Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis

por Mostaghel, Elahe A., Morgan, Andrew, Zhang, Xiaotun, Marck, Brett T., Xia, Jing, Hunter-Merrill, Rachel, Gulati, Roman, Plymate, Stephen, Vessella, Robert L., Corey, Eva, Higano, Celestia S., Matsumoto, Alvin M., Montgomery, R. Bruce, Nelson, Peter S.
Publicado 2014

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an­­d Serve as Models for Evaluating Cancer Therapeutics

por Nguyen, Holly M., Vessella, Robert L., Morrissey, Colm, Brown, Lisha G., Coleman, Ilsa M., Higano, Celestia S., Mostaghel, Elahe A., Zhang, Xiaotun, True, Lawrence D., Lam, Hung‐Ming, Roudier, Martine, Lange, Paul H., Nelson, Peter S., Corey, Eva
Publicado 2017

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

por Mostaghel, Elahe A., Marck, Brett T., Kolokythas, Orpheus, Chew, Felix, Yu, Evan Y., Schweizer, Michael T., Cheng, Heather H., Kantoff, Phillip W., Balk, Steven P., Taplin, Mary-Ellen, Sharifi, Nima, Matsumoto, Alvin M., Nelson, Peter S., Montgomery, R. Bruce
Publicado 2021

Association of Prostate Cancer SLCO Gene Expression with Gleason Grade and Alterations Following Androgen Deprivation Therapy

por Alsinnawi, Mazen, Zhang, Ailin, Bianchi-Frias, Daniella, Burns, John, Cho, Eunpi, Zhang, Xiaotun, Sowalsky, Adam, Ye, Huihui, Slee, April E., True, Lawrence, Porter, Christopher, Taplin, Mary-Ellen, Balk, Steven, Nelson, Peter S, Montgomery, R. Bruce, Mostaghel, Elahe A
Publicado 2019

Sigma1 Regulates Lipid Droplet–Mediated Redox Homeostasis Required for Prostate Cancer Proliferation

por Oyer, Halley M., Steck, Alexandra R., Longen, Charles G., Venkat, Sanjana, Bayrak, Konuralp, Munger, Eleanor B., Fu, Dan, Castagnino, Paola A., Sanders, Christina M., Tancler, Nathalia A., Mai, My T., Myers, Justin P., Schiewer, Matthew J., Chen, Nan, Mostaghel, Elahe A., Kim, Felix J.
Publicado 2023